Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Wakeling

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Current Opinion in Pharmacology|July 20, 2002
Epidermal growth factor receptor tyrosine kinase inhibitorsAlan E Wakeling
Bailliere'S Clinical Endocrinology and Metabolism|March 1, 1990
Mechanisms of growth regulation of human breast cancerA E Wakeling
The Journal of Steroid Biochemistry and Molecular Biology|December 1, 1993
Are breast tumours resistant to tamoxifen also resistant to pure antioestrogens?A E Wakeling
Journal of Steroid Biochemistry|January 1, 1989
Comparative studies on the effects of steroidal and nonsteroidal oestrogen antagonists on the proliferation of human breast cancer cellsA E Wakeling
Hormone Research|January 1, 1989
The potential for a novel pure anti-oestrogenA E Wakeling
Breast Cancer Research and Treatment|January 1, 1993
The future of new pure antiestrogens in clinical breast cancerA E Wakeling
Mutation Research|December 1, 1995
Tissue-specific actions of antioestrogensA E Wakeling
Endocrine-Related Cancer|August 23, 2005
Inhibitors of growth factor signallingA E Wakeling
Annals of the New York Academy of Sciences|January 1, 1990
Novel pure antiestrogens. Mode of action and therapeutic prospectsA E Wakeling
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Therapeutic potential of pure antioestrogens in the treatment of breast cancerA E Wakeling
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Current Opinion in Pharmacology|July 20, 2002
Epidermal growth factor receptor tyrosine kinase inhibitorsAlan E Wakeling
Bailliere'S Clinical Endocrinology and Metabolism|March 1, 1990
Mechanisms of growth regulation of human breast cancerA E Wakeling
The Journal of Steroid Biochemistry and Molecular Biology|December 1, 1993
Are breast tumours resistant to tamoxifen also resistant to pure antioestrogens?A E Wakeling
Journal of Steroid Biochemistry|January 1, 1989
Comparative studies on the effects of steroidal and nonsteroidal oestrogen antagonists on the proliferation of human breast cancer cellsA E Wakeling
Hormone Research|January 1, 1989
The potential for a novel pure anti-oestrogenA E Wakeling
Breast Cancer Research and Treatment|January 1, 1993
The future of new pure antiestrogens in clinical breast cancerA E Wakeling
Mutation Research|December 1, 1995
Tissue-specific actions of antioestrogensA E Wakeling
Endocrine-Related Cancer|August 23, 2005
Inhibitors of growth factor signallingA E Wakeling
Annals of the New York Academy of Sciences|January 1, 1990
Novel pure antiestrogens. Mode of action and therapeutic prospectsA E Wakeling
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Therapeutic potential of pure antioestrogens in the treatment of breast cancerA E Wakeling
Pageof 9